How can I determine if my atorvastatin tablets are enteric‑coated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Atorvastatin Tablets Are Not Enteric-Coated

Atorvastatin tablets are film-coated, not enteric-coated, and this distinction is clinically important because enteric coatings delay drug absorption by 3-4 hours. 1

How to Identify Your Atorvastatin Formulation

Visual Identification from FDA Labeling

  • Atorvastatin calcium tablets are described as "white to off-white, oval, biconvex film-coated tablets" with specific engravings (e.g., "APO" on one side, dose identifier on the other). 1
  • The FDA label explicitly states these are film-coated, not enteric-coated formulations. 1

Key Differences Between Film-Coated and Enteric-Coated Tablets

Absorption characteristics:

  • Film-coated atorvastatin is rapidly absorbed in the stomach and upper intestine, with peak plasma levels reached within 1-4 hours after ingestion. 2, 3
  • Enteric-coated formulations (used for aspirin, pancreatic enzymes) are designed to resist gastric acid and dissolve only at pH >5.5 in the duodenum, delaying peak levels by 3-4 hours. 4

Physical appearance:

  • Enteric-coated tablets typically have a glossy, smooth coating that protects against moisture and gastric acid, often appearing more uniform and shiny than standard film coatings. 5, 6
  • Film-coated tablets like atorvastatin have a thinner coating primarily for aesthetic purposes, taste masking, and ease of swallowing—not for acid resistance. 1

Clinical Implications of Atorvastatin's Film Coating

Dosing Flexibility

  • Atorvastatin can be taken at any time of day, with or without food, because the film coating does not require specific pH conditions for dissolution. 1
  • Food decreases the absorption rate (lower peak concentration, longer time to peak) but does not significantly affect clinical efficacy. 2

No Need for Gastric Protection

  • Unlike enteric-coated aspirin (which requires 3-4 hours to reach therapeutic levels), atorvastatin achieves therapeutic plasma concentrations within 1-4 hours regardless of gastric pH. 4, 2
  • The film coating provides no protection against gastric acid, nor is such protection necessary for atorvastatin's mechanism of action. 1, 3

Common Pitfalls to Avoid

  • Do not confuse film-coated with enteric-coated: Film coatings are cosmetic and functional (ease of swallowing), while enteric coatings are pharmaceutical barriers designed to delay drug release until the small intestine. 5, 6
  • Do not assume all coated tablets are enteric-coated: Most statins, including atorvastatin, use simple film coatings that dissolve immediately upon contact with gastric fluid. 1, 2
  • Do not crush or chew atorvastatin tablets: While the film coating is not enteric, crushing may alter absorption kinetics and is not recommended per FDA labeling. 1

References

Research

Clinical pharmacokinetics of atorvastatin.

Clinical pharmacokinetics, 2003

Research

Atorvastatin: a hydroxymethylglutaryl-coenzyme A reductase inhibitor.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2019

Research

Development of an enteric coating formulation and process for tablets primarily composed of a highly water-soluble, organic acid.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.